Editorial / commentary
Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply.
The New England journal of medicine · 26 Oct 2023
Record
Publication details
- Authors
- Jastreboff AM, Kaplan LM, Hartman ML
- Journal
- The New England journal of medicine
- Publication date
- 26 Oct 2023
- Publication type
- Letter; Comment
- Evidence type
- Editorial / commentary
- Relevance classification
- Primary
- PubMed ID
- 37888927
- DOI
- 10.1056/NEJMc2310645
- Language
- eng
- Linked clinical trial
- Not reported
Abstract
Abstract not reported by the source record.
Why this paper matters
Editorial analysis pending